Our findings indicate that TCF2 expression is lost in ovarian cancer cell lines that show methylation and that expression is restored by treating cells with a methyltransferase inhibitor, confirming epigenetic silencing of the gene. Here, HNF1B is linked to ovarian carcinoma.